Skip to main content

ImaGenes to Offer Roche NimbleGen Micorarrays

NEW YORK (GenomeWeb News) – Genomics services provider ImaGenes has received certification from Roche NimbleGen to offer NimbleGen microarrays for chromatin immunoprecipitation (ChIP-chip) services, Roche NimbleGen said today.

Berlin-based ImaGenes passed a ChIP-chip certification using the NimbleGen Dual-Color workflow and the MS 200 Microarray Scanner to become a certified service provider. This certification enables ImaGenes to process samples for DNA-protein interactions and chromatin structure.

Roche NimbleGen CEO Gerd Maass said in a statement that ImaGenes "will further expand our business in the German market and fuel the basic research that is vital to the personalized healthcare pipeline."

ImaGenes offers a range of research services, including microarray and RT-qPCR applications, next-generation sequencing, and access to a mammalian and vertebrate clone collection.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.